Anna-Shari Melin

ANNA-SHARI MELIN is a life sciences lawyer and German Rechtsanwältin. She advises clients on a broad range of EU and German regulatory and compliance matters that impact pharmaceutical, biotechnology, medical device and in-vitro diagnostic manufacturers; food business operators; cosmetic products and consumer goods manufacturers and distributors; digital health companies; and private equity firms focused on life sciences.

Her matters range across the product life cycle and include analyses and strategies/risk assessments pertaining to clinical trials, good manufacturing practice compliance, early access programs and market access, pharmacovigilance, medicinal product shortages, recalls, the new medical devices regulations, pharmaceutical/device advertising and related compliance. She has represented clients in matters before the European Commission, the European Medicines Agency and numerous Member State authorities.

In addition to EU life sciences regulatory issues, Anna-Shari routinely helps clients conduct due diligence in connection with mergers and acquisitions, and advises on anti-corruption compliance and government enforcement across Europe and, in particular, in Germany. Anna-Shari has also gathered significant experience in the area of health-related competition law, particularly in connection with pay-for-delay appeals in the EU and the UK.

Prior to joining the firm, Anna-Shari gained experience at other international law firms, as well as German courts.